title: Reduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis.
abstract: The peroxisome proliferator-activated receptor α (PPAR-α) is a member of the nuclear receptor family with many important physiologic roles related to metabolism and inflammation. Previous research in pediatric patients with septic shock revealed that genes corresponding to the PPAR-α signaling pathway are significantly downregulated in a subgroup of children with more severe disease. In this study, PPAR-α expression analysis using whole-blood derived RNA revealed that PPAR-α expression was decreased in patients with septic shock and that the magnitude of that decrement correlated with the severity of disease. In a mouse model of sepsis, induced by cecal ligation and puncture, knockout mice lacking PPAR-α had decreased survival compared with wild-type animals. Plasma cytokine analysis demonstrated decreased levels of interleukin 1β (IL-1β), IL-6, IL-17, keratinocyte-derived cytokine, macrophage chemoattractant protein 1, macrophage inflammatory protein 2, and tumor necrosis factor α at 24 h in PPAR-α knockout animals. Cell surface markers of activation on splenic dendritic cells, macrophages, and CD8 T cells were reduced in PPAR-α null animals, and the bacterial load in lung and splenic tissues was increased. These data indicate that reduced or absent PPAR-α expression confers a survival disadvantage in sepsis and that PPAR-α plays a role in maintaining appropriate immune functions during the sepsis response.
authors.affiliation: Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. sws24@u.washington.edu
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Standage
authors.forename: Charles C
authors.initials: CC
authors.lastname: Caldwell
authors.forename: Basilia
authors.initials: B
authors.lastname: Zingarelli
authors.forename: Hector R
authors.initials: HR
authors.lastname: Wong
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D007223:Infant; D015603:Keratinocytes / Q000166:cytology; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D047493:PPAR alpha / Q000096:biosynthesis*; D018805:Sepsis / Q000378:metabolism* / Q000382:microbiology* / Q000401:mortality; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016207:Cytokines; D047493:PPAR alpha
references.citation: Endocrinology. 2003 Jun;144(6):2201-7
references.pmid: 12746275
references.citation: Eur Respir J. 2008 Nov;32(5):1344-53
references.pmid: 18653653
references.citation: J Immunol. 2002 Dec 15;169(12):6806-12
references.pmid: 12471112
references.citation: Nature. 1998 Jan 1;391(6662):79-82
references.pmid: 9422508
references.citation: J Clin Invest. 2006 Mar;116(3):598-606
references.pmid: 16511592
references.citation: Crit Care Med. 2009 May;37(5):1558-66
references.pmid: 19325468
references.citation: J Clin Invest. 2011 Jun;121(6):2111-7
references.pmid: 21633179
references.citation: Pediatr Crit Care Med. 2010 May;11(3):349-55
references.pmid: 20009785
references.citation: Nature. 2000 May 25;405(6785):421-4
references.pmid: 10839530
references.citation: J Mol Cell Cardiol. 2008 Jun;44(6):968-75
references.pmid: 18462747
references.citation: Diabetes. 2004 Feb;53 Suppl 1:S43-50
references.pmid: 14749265
references.citation: N Engl J Med. 2003 Jan 9;348(2):138-50
references.pmid: 12519925
references.citation: Physiol Genomics. 2007 Jul 18;30(2):146-55
references.pmid: 17374846
references.citation: Clin Chest Med. 2008 Dec;29(4):617-25, viii
references.pmid: 18954697
references.citation: Shock. 2005 Dec;24 Suppl 1:52-7
references.pmid: 16374373
references.citation: PPAR Res. 2008;2008:546753
references.pmid: 18645614
references.citation: J Biol Chem. 2008 Oct 24;283(43):29109-18
references.pmid: 18701451
references.citation: J Immunol. 2003 Dec 15;171(12):6827-37
references.pmid: 14662889
references.citation: Mol Med. 2007 Sep-Oct;13(9-10):495-508
references.pmid: 17932561
references.citation: BMC Med. 2009 Jul 22;7:34
references.pmid: 19624809
references.citation: Nat Med. 2009 May;15(5):496-7
references.pmid: 19424209
references.citation: Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):619-26
references.pmid: 18838972
references.citation: J Immunol. 2001 Dec 1;167(11):6140-9
references.pmid: 11714773
references.citation: Annu Rev Physiol. 2010;72:219-46
references.pmid: 20148674
references.citation: Trends Immunol. 2007 Dec;28(12):551-8
references.pmid: 17981503
references.citation: Circulation. 2007 Jan 30;115(4):518-33
references.pmid: 17261671
references.citation: J Pharmacol Exp Ther. 2009 Feb;328(2):635-43
references.pmid: 18997058
references.citation: Shock. 2005 May;23(5):393-9
references.pmid: 15834303
references.citation: Shock. 2009 Mar;31(3):308-16
references.pmid: 18665053
references.citation: Pediatr Crit Care Med. 2005 Jan;6(1):2-8
references.pmid: 15636651
references.citation: Nat Rev Immunol. 2006 Jan;6(1):44-55
references.pmid: 16493426
references.citation: Nature. 2008 Jul 24;454(7203):470-7
references.pmid: 18650918
references.citation: Nat Immunol. 2005 Oct;6(10):966-7
references.pmid: 16177802
references.citation: J Immunol. 2009 Apr 1;182(7):4479-87
references.pmid: 19299749
references.citation: Pharmacol Res. 2005 Feb;51(2):85-94
references.pmid: 15629253
references.citation: Shock. 2006 Nov;26(5):477-84
references.pmid: 17047518